New study points to a better way to ward off asthma triggers
(La Jolla Institute for Immunology) Every day, ten Americans die from asthma. While quick-acting inhalers and medications can reduce inflammation during an asthma attack, people with asthma have few tools to prevent the next attack from coming.Now researchers at La Jolla Institute for Immunology (LJI) have discovered that blocking two immune molecules at the same time is key to preventing asthma attacks in a mouse model.
Source: EurekAlert! - Biology - November 11, 2020 Category: Biology Source Type: news

Fighting Zika? Call in the T cells
(La Jolla Institute for Immunology) In a new Science Advances study, Shresta and her colleagues at LJI report that the immune system's T cells have the power to prevent Zika infection in mice. This finding suggests that effective Zika vaccines need to activate T cells to work alongside antibodies.
Source: EurekAlert! - Infectious and Emerging Diseases - November 4, 2020 Category: Infectious Diseases Source Type: news

Pancreas Cells That Drive Type 1 Diabetes Appear in Healthy People, Too
WEDNESDAY, Oct. 21, 2020 -- Scientists knew that dangerous T-cells lived in the pancreases of people with type 1 diabetes, but a new study shows they also take up residence in the pancreases of healthy individuals. Researchers from the La Jolla...
Source: Drugs.com - Daily MedNews - October 21, 2020 Category: General Medicine Source Type: news

Every COVID-19 case seems different; these scientists want to know why
(La Jolla Institute for Immunology) As scientists around the world develop life-saving COVID-19 vaccines and therapies, many are still wondering exactly why the disease proves deadly in some people and mild in others.A new international study led by scientists at La Jolla Institute for Immunology (LJI), The University of Liverpool and the University of Southampton is the first to give a detailed snapshot of how the body's CD4+ T cells respond to the SARS-CoV-2 virus.
Source: EurekAlert! - Medicine and Health - October 6, 2020 Category: International Medicine & Public Health Source Type: news

This is why Covid-19 could be life-threatening for some patients
“It looks like this virus has one big trick,” said Shane Crotty, a professor in the Center for Infectious Disease and Vaccine Research at the La Jolla Institute for Immunology in California.
Source: The Economic Times - September 24, 2020 Category: Consumer Health News Source Type: news

A step toward helping patients breathe deeply
(La Jolla Institute for Immunology) In a new study, researchers at La Jolla Institute for Immunology (LJI) report that a protein called TL1A drives fibrosis in several mouse models, triggering tissue remodeling, and making it harder for lungs and airways to function normally.
Source: EurekAlert! - Medicine and Health - September 24, 2020 Category: International Medicine & Public Health Source Type: news

Commentary: Theaters nobly fill the COVID void, but screens make me miss the stage even more
Productions from the Fountain, A.C.T., Pig Iron and La Jolla Playhouse are admirably ambitious at times, but they also reveal the limits of digital.
Source: L.A. Times - Health - September 23, 2020 Category: Consumer Health News Authors: Charles McNulty Source Type: news

UC San Diego tries to avoid the coronavirus chaos that has upended San Diego State
The La Jolla school will rely heavily on technology and peer pressure as thousands of students populate its dorms.
Source: L.A. Times - Health - September 22, 2020 Category: Consumer Health News Authors: Gary Robbins Source Type: news

T cells take the lead in controlling SARS-CoV-2 and reducing COVID-19 disease severity
Ever since SARS-CoV-2 first appeared, researchers have been trying to understand whether sometimes the immune system does more harm than good during the acute phase of COVID-19. The latest study by researchers at La Jolla Institute for Immunology clearly argues in favor of the immune system.
Source: World Pharma News - September 16, 2020 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Beating HIV and COVID-19 may depend on tweaking vaccine molecules
(La Jolla Institute for Immunology) In a new Immunity study, researchers at La Jolla Institute for Immunology (LJI) show that one way to improve the body's immune response to vaccines is to factor in antigen valency. Valency refers to the number of antibody binding sites on an antigen.
Source: EurekAlert! - Medicine and Health - August 27, 2020 Category: International Medicine & Public Health Source Type: news

LJI team gets first-ever look at a rare but vital stem cell in humans
(La Jolla Institute for Immunology) Scientists at La Jolla Institute for Immunology (LJI) have tracked down the rare stem cells that generate neutrophils in human bone marrow. This research, published August 18, 2020, in Immunity, gives researchers a potential path for intervening in diseases where neutrophil development goes awry.
Source: EurekAlert! - Infectious and Emerging Diseases - August 18, 2020 Category: Infectious Diseases Source Type: news

Exposure to common cold coronaviruses can teach the immune system to recognize SARS-CoV-2
(La Jolla Institute for Immunology) A new study led by scientists at La Jolla Institute for Immunology (LJI) shows that memory helper T cells that recognize common cold coronaviruses also recognize matching sites on SARS-CoV-2, the virus that causes COVID-19.
Source: EurekAlert! - Infectious and Emerging Diseases - August 4, 2020 Category: Infectious Diseases Source Type: news

T cells can shift from helping to harming in atherosclerosis
(La Jolla Institute for Immunology) At La Jolla Institute for Immunology (LJI) researchers are dedicated to finding a way to stop plaques from forming in the first place. In a new study, LJI scientists show that certain T lymphocytes, a type of white blood cell, that start out trying to fight the disease can end up increasing inflammation and making atherosclerosis cases even worse.
Source: EurekAlert! - Medicine and Health - July 24, 2020 Category: International Medicine & Public Health Source Type: news

Study: New Form Of Coronavirus Spreads Faster, But Doesn ’ t Make People Sicker
(CNN) — A global study has found strong evidence that a new form of the coronavirus has spread from Europe to the US. The new mutation makes the virus more likely to infect people but does not seem to make them any sicker than earlier variations of the virus, an international team of researchers reported Thursday. “It is now the dominant form infecting people,” Erica Ollmann Saphire of the La Jolla Institute for Immunology and the Coronavirus Immunotherapy Consortium, who worked on the study, told CNN. “This is now the virus.” The study, published in the journal Cell, builds on some earlier wo...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - July 3, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Syndicated CBSN Boston CNN Coronavirus Source Type: news

Pages: 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20